Overview

Rosuvastatin in Visceral Adiposity

Status:
Completed

Trial end date:
2008-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to investigate whether 6 months treatment with the cholesterol-lowering drug rosuvastatin may reduce visceral fat tissue in obese middle aged men.

Phase:

Phase 3

Details

Lead Sponsor:

Göteborg University

Collaborator:

Sahlgrenska University Hospital, Sweden

Treatments:

Rosuvastatin Calcium